's Hot Lunchtime Reads 8/5: (MU) (MRK) (LGND) (FIVE)

August 5, 2016 12:12 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

The following is a list of notable articles to help get you through the lunch hour:
  • Micron (MU) Gains as UBS Research Suggests DRAM Price Stability -> Read this!

  • Deutsche Bank Comments on Bristol-Myers Squibb (BMY) Opdivo News; Analyst Says Merck (MRK) Not Guaranteed to be Alone in Front-Line Setting -> Read this!

  • Roth Capital Says to Buy Ligand Pharma (LGND) on Today's 'Bad' Downgrade -> Read this!

  • Five Below (FIVE) to Benefit from Pokemon Go Craze - UBS -> Read this!

  • Vale S.A. (VALE) said in talks to sell entire fertilizer business - Bloomberg -> Read this!

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Special Reports

Related Entities

Deutsche Bank, UBS, Roth Capital

Add Your Comment